NASDAQ:MLAB Mesa Laboratories (MLAB) Stock Price, News & Analysis $139.01 +3.81 (+2.82%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$136.04 -2.97 (-2.14%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Mesa Laboratories Stock (NASDAQ:MLAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Mesa Laboratories alerts:Sign Up Key Stats Today's Range$134.19▼$140.9350-Day Range$119.30▼$142.2352-Week Range$69.51▼$144.35Volume87,350 shsAverage Volume106,104 shsMarket Capitalization$781.38 millionP/E Ratio121.94Dividend Yield0.46%Price Target$130.00Consensus RatingHold Company Overview Mesa Laboratories, Inc. develops and manufactures instruments and consumable products used to monitor and control quality in life sciences and other regulated industries. Its offerings support activities such as sterilization and disinfection monitoring, laboratory testing, biopharmaceutical development, and equipment calibration. The company’s products include biological and chemical indicators, data loggers, calibration instruments, and tools used in clinical genomics and bioprocessing. Customers use these products to help verify processes, measure conditions, and meet quality requirements. Founded in 1982, Mesa Laboratories serves customers in the United States and international markets, including pharmaceutical, healthcare, and laboratory organizations.AI Generated. May Contain Errors. Read More Mesa Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreMLAB MarketRank™: 0.886441122475 of 5 starsMesa Laboratories scored higher than 18% of companies evaluated by MarketBeat, and ranked 832nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingHold Consensus RatingMesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and no sell ratings.Downside RiskMesa Laboratories has a consensus price target of $130.00, representing about 6.5% downside from its current price of $139.01.Amount of Analyst CoverageMesa Laboratories has only been the subject of 2 research reports in the past 90 days.Read more about Mesa Laboratories' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is 121.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is 121.94, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 4.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.93% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 4.68.Change versus previous monthShort interest in Mesa Laboratories has recently decreased by 3.43%, indicating that investor sentiment is improving. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldMesa Laboratories has a dividend yield of 0.46%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mesa Laboratories is 56.14%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Mesa Laboratories' dividend. News and Social Media2.7 / 5News Sentiment0.32 News SentimentMesa Laboratories has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Mesa Laboratories this week, compared to 2 articles on an average week.Search Interest3 people have searched for MLAB on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have not sold or bought any company stock.Percentage Held by Insiders2.80% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mesa Laboratories' insider trading history. Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLAB Stock News HeadlinesMesa Laboratories, Inc. 2027 Q2 - Results - Earnings Call PresentationNovember 12 at 6:34 PM | seekingalpha.comJefferies Financial Group Forecasts Strong Price Appreciation for Mesa Laboratories (NASDAQ:MLAB) StockNovember 12 at 1:25 AM | americanbankingnews.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 15 at 1:00 AM | Behind the Markets (Ad)Mesa Laboratories, Inc. (MLAB) Q2 2027 Earnings Call TranscriptNovember 10, 2026 | seekingalpha.comMesa Labs (MLAB) Q2 2027 Earnings Call TranscriptNovember 10, 2026 | finance.yahoo.comMesa Laboratories Q2 2027 Earnings Call TranscriptNovember 9, 2026 | benzinga.comMesa Laboratories Reports Second-Quarter Fiscal 2027 Results, Raises Outlook and Announces $40 Million Share Repurchase ProgramNovember 9, 2026 | quiverquant.comQMesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year GuidanceNovember 9, 2026 | globenewswire.comSee More Headlines MLAB Stock Analysis - Frequently Asked Questions How have MLAB shares performed this year? Mesa Laboratories' stock was trading at $78.50 on January 1st, 2026. Since then, MLAB stock has increased by 77.1% and is now trading at $139.01. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its earnings results on Monday, August, 10th. The medical instruments supplier reported $2.68 EPS for the quarter. The medical instruments supplier earned $60.14 million during the quarter. Mesa Laboratories had a net margin of 2.65% and a trailing twelve-month return on equity of 22.77%. Read the conference call transcript. Who are Mesa Laboratories' major shareholders? Mesa Laboratories' top institutional shareholders include State Street Corp (2.41%), William Blair Investment Management LLC (2.33%), Aberdeen Group plc (1.81%) and Russell Investments Group Ltd. (1.28%). Insiders that own company stock include Gary M Owens, John Sakys, John James Sullivan, Shiraz Shabanali Ladiwala, Siddhartha Kadia, Brian David Archbold, R Tony Tripeny, Mark Christopher Capone and Lyndsey Elizabeth Crennen. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include Intel (INTC), NVIDIA (NVDA), Walt Disney (DIS), Lennar (LEN), Southwest Airlines (LUV), Advanced Micro Devices (AMD) and Gilead Sciences (GILD). Company Calendar Last Earnings8/10/2026Record date for 9/15 Dividend8/31/2026Ex-Dividend for 9/15 Dividend8/31/2026Dividend Payable9/15/2026Today11/15/2026Record date for 12/15 Dividend11/30/2026Ex-Dividend for 12/15 Dividend11/30/2026Dividend Payable12/15/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (10m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 MLAB's financial health is in the Green zone, according to TradeSmith. MLAB has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:MLAB CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees717Year Founded1982Price Target and Rating Average Price Target for Mesa Laboratories$130.00 High Price Target$150.00 Low Price Target$110.00 Potential Upside/Downside-6.5%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$1.14 Trailing P/E Ratio121.94 Forward P/E RatioN/A P/E GrowthN/ANet Income$6.71 million Net Margins2.65% Pretax Margin5.33% Return on Equity22.77% Return on Assets10.19% Debt Debt-to-Equity Ratio0.65 Current Ratio1.90 Quick Ratio1.32 Sales & Book Value Annual Sales$251.32 million Price / Sales3.11 Cash Flow$12.11 per share Price / Cash Flow11.48 Book Value$34.62 per share Price / Book4.02Miscellaneous Outstanding Shares5,621,000Free Float5,464,000Market Cap$781.38 million OptionableNot Optionable Beta1.08 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:MLAB) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
